Accendra Health Total Assets Growth & History (ACH)
Accendra Health's total assets was $2.45B for fiscal 2025.
View full Accendra Health company overviewAccendra Health annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.45B | −$2.20B | −47.34% |
| 2024 | 2024-12-31 | $4.66B | −$437.2M | −8.58% |
| 2023 | 2023-12-31 | $5.09B | −$293.0M | −5.44% |
| 2022 | 2022-12-31 | $5.39B | $1.85B | +52.30% |
| 2021 | 2021-12-31 | $3.54B | $200.9M | +6.02% |
| 2020 | 2020-12-31 | $3.34B | −$307.4M | −8.44% |
| 2019 | 2019-12-31 | $3.64B | −$130.7M | −3.46% |
| 2018 | 2018-12-31 | $3.77B | $397.5M | +11.77% |
| 2017 | 2017-12-31 | $3.38B | $658.5M | +24.23% |
| 2016 | 2016-12-31 | $2.72B | −$56.0M | −2.02% |
| 2015 | 2015-12-31 | $2.77B | $38.4M | +1.40% |
| 2014 | 2014-12-31 | $2.74B | $411.4M | +17.70% |
| 2013 | 2013-12-31 | $2.32B | $109.6M | +4.95% |
| 2012 | 2012-12-31 | $2.21B | $267.6M | +13.74% |
| 2011 | 2011-12-31 | $1.95B | $124.8M | +6.85% |
| 2010 | 2010-12-31 | $1.82B | $75.0M | +4.29% |
| 2009 | 2009-12-31 | $1.75B | — | — |
Accendra Health quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.11B | −$2.05B | −49.27% |
| Q1 2026 | 2026-03-31 | $2.42B | −$2.44B | −50.25% |
| Q4 2025 | 2025-12-31 | $2.45B | −$2.20B | −47.34% |
| Q3 2025 | 2025-09-30 | $4.04B | −$1.05B | −20.57% |
| Q2 2025 | 2025-06-30 | $4.15B | −$1.15B | −21.67% |
| Q1 2025 | 2025-03-31 | $4.86B | −$351.6M | −6.75% |
| Q4 2024 | 2024-12-31 | $4.66B | −$437.2M | −8.58% |
| Q3 2024 | 2024-09-30 | $5.08B | −$42.8M | −0.83% |
| Q2 2024 | 2024-06-30 | $5.30B | $16.0M | +0.30% |
| Q1 2024 | 2024-03-31 | $5.21B | −$102.2M | −1.92% |
| Q4 2023 | 2023-12-31 | $5.09B | −$293.0M | −5.44% |
| Q3 2023 | 2023-09-30 | $5.12B | −$414.5M | −7.48% |
| Q2 2023 | 2023-06-30 | $5.29B | −$267.3M | −4.81% |
| Q1 2023 | 2023-03-31 | $5.31B | −$397.8M | −6.97% |
| Q4 2022 | 2022-12-31 | $5.39B | $1.85B | +52.30% |
| Q3 2022 | 2022-09-30 | $5.54B | $1.95B | +54.53% |
| Q2 2022 | 2022-06-30 | $5.56B | $1.96B | +54.66% |
| Q1 2022 | 2022-03-31 | $5.71B | $2.32B | +68.34% |
| Q4 2021 | 2021-12-31 | $3.54B | $200.9M | +6.02% |
| Q3 2021 | 2021-09-30 | $3.58B | $287.0M | +8.70% |
| Q2 2021 | 2021-06-30 | $3.59B | $454.0M | +14.47% |
| Q1 2021 | 2021-03-31 | $3.39B | −$324.0M | −8.72% |
| Q4 2020 | 2020-12-31 | $3.34B | −$307.4M | −8.44% |
| Q3 2020 | 2020-09-30 | $3.30B | −$391.3M | −10.61% |
| Q2 2020 | 2020-06-30 | $3.14B | −$758.3M | −19.46% |
| Q1 2020 | 2020-03-31 | $3.71B | −$167.5M | −4.31% |
| Q4 2019 | 2019-12-31 | $3.64B | −$130.7M | −3.46% |
| Q3 2019 | 2019-09-30 | $3.69B | −$343.9M | −8.53% |
| Q2 2019 | 2019-06-30 | $3.90B | −$147.1M | −3.64% |
| Q1 2019 | 2019-03-31 | $3.88B | $490.8M | +14.47% |
| Q4 2018 | 2018-12-31 | $3.77B | $397.5M | +11.77% |
| Q3 2018 | 2018-09-30 | $4.03B | $698.1M | +20.94% |
| Q2 2018 | 2018-06-30 | $4.04B | $1.25B | +44.65% |
| Q1 2018 | 2018-03-31 | $3.39B | $691.0M | +25.59% |
| Q4 2017 | 2017-12-31 | $3.38B | $658.5M | +24.23% |
| Q3 2017 | 2017-09-30 | $3.33B | $539.5M | +19.31% |
| Q2 2017 | 2017-06-30 | $2.80B | $39.1M | +1.42% |
| Q1 2017 | 2017-03-31 | $2.70B | −$96.3M | −3.44% |
| Q4 2016 | 2016-12-31 | $2.72B | −$56.0M | −2.02% |
| Q3 2016 | 2016-09-30 | $2.79B | $43.0M | +1.56% |
| Q2 2016 | 2016-06-30 | $2.76B | −$38.8M | −1.39% |
| Q1 2016 | 2016-03-31 | $2.80B | $97.3M | +3.61% |
| Q4 2015 | 2015-12-31 | $2.77B | $38.4M | +1.40% |
| Q3 2015 | 2015-09-30 | $2.75B | −$192.2M | −6.53% |
| Q2 2015 | 2015-06-30 | $2.79B | $431.1M | +18.24% |
| Q1 2015 | 2015-03-31 | $2.70B | $330.3M | +13.94% |
| Q4 2014 | 2014-12-31 | $2.74B | $411.4M | +17.70% |
| Q3 2014 | 2014-09-30 | $2.94B | $596.2M | +25.40% |
| Q2 2014 | 2014-06-30 | $2.36B | −$15.7M | −0.66% |
| Q1 2014 | 2014-03-31 | $2.37B | $48.3M | +2.08% |
| Q4 2013 | 2013-12-31 | $2.32B | $109.6M | +4.95% |
| Q3 2013 | 2013-09-30 | $2.35B | $125.9M | +5.67% |
| Q2 2013 | 2013-06-30 | $2.38B | $424.1M | +21.69% |
| Q1 2013 | 2013-03-31 | $2.32B | $396.1M | +20.58% |
| Q4 2012 | 2012-12-31 | $2.21B | $267.6M | +13.74% |
| Q3 2012 | 2012-09-30 | $2.22B | $272.1M | +13.96% |
| Q2 2012 | 2012-06-30 | $1.96B | $49.6M | +2.60% |
| Q1 2012 | 2012-03-31 | $1.92B | $13.6M | +0.71% |
| Q4 2011 | 2011-12-31 | $1.95B | $124.8M | +6.85% |
| Q3 2011 | 2011-09-30 | $1.95B | $108.3M | +5.88% |
| Q2 2011 | 2011-06-30 | $1.91B | $101.1M | +5.60% |
| Q1 2011 | 2011-03-31 | $1.91B | — | — |
| Q4 2010 | 2010-12-31 | $1.82B | $75.0M | +4.29% |
| Q3 2010 | 2010-09-30 | $1.84B | — | — |
| Q2 2010 | 2010-06-30 | $1.80B | — | — |
| Q4 2009 | 2009-12-31 | $1.75B | — | — |
Accendra Health total assets trends
Over the last five fiscal years, Accendra Health's total assets decreased from $3.34B to $2.45B, a change of −$883.9M. The latest reported quarter, Q2 2026, shows $2.11B.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Accendra Health source filings ↗